Ligand Pharmaceuticals Statistics
Total Valuation
BABYF has a market cap or net worth of 5.02 million. The enterprise value is 5.55 million.
| Market Cap | 5.02M |
| Enterprise Value | 5.55M |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 374.11M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +29.23% |
| Shares Change (QoQ) | +27.46% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 343.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.91 |
| PB Ratio | 4.12 |
| P/TBV Ratio | 4.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.53 |
| EV / Sales | 0.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.88 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.18 |
| Quick Ratio | 0.21 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -211.81 |
Financial Efficiency
Return on equity (ROE) is -358.24% and return on invested capital (ROIC) is -145.37%.
| Return on Equity (ROE) | -358.24% |
| Return on Assets (ROA) | -76.19% |
| Return on Invested Capital (ROIC) | -145.37% |
| Return on Capital Employed (ROCE) | -820.68% |
| Revenue Per Employee | 426,251 |
| Profits Per Employee | -811,658 |
| Employee Count | 13 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 1.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.09% in the last 52 weeks. The beta is 2.53, so BABYF's price volatility has been higher than the market average.
| Beta (5Y) | 2.53 |
| 52-Week Price Change | -66.09% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 55.70 |
| Average Volume (20 Days) | 264,752 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BABYF had revenue of 5.54 million and -10.55 million in losses. Loss per share was -0.06.
| Revenue | 5.54M |
| Gross Profit | -807,595 |
| Operating Income | -10.01M |
| Pretax Income | -10.55M |
| Net Income | -10.55M |
| EBITDA | -9.92M |
| EBIT | -10.01M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 71,585 in cash and 568,514 in debt, giving a net cash position of -496,928.
| Cash & Cash Equivalents | 71,585 |
| Total Debt | 568,514 |
| Net Cash | -496,928 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.22M |
| Book Value Per Share | 0.01 |
| Working Capital | 721,414 |
Cash Flow
In the last 12 months, operating cash flow was -6.30 million and capital expenditures -43,090, giving a free cash flow of -6.34 million.
| Operating Cash Flow | -6.30M |
| Capital Expenditures | -43,090 |
| Free Cash Flow | -6.34M |
| FCF Per Share | n/a |
Margins
Gross margin is -14.57%, with operating and profit margins of -180.65% and -190.42%.
| Gross Margin | -14.57% |
| Operating Margin | -180.65% |
| Pretax Margin | -190.42% |
| Profit Margin | -190.42% |
| EBITDA Margin | -179.03% |
| EBIT Margin | -180.65% |
| FCF Margin | n/a |
Dividends & Yields
BABYF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -29.23% |
| Shareholder Yield | n/a |
| Earnings Yield | -210.19% |
| FCF Yield | -126.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BABYF has an Altman Z-Score of -17.45 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.45 |
| Piotroski F-Score | 2 |